Well that takes away three worries. 1. What the financial agreement with NeuroRx actually looks like. 2. Will they merge. 3. Will rights be sold, excluding Relief's shareholders from future profits. All in all a very fair agreement that incentivises both sides. I read this as Relief and NeuroRx are in it for the long haul and aren't necessarily planning on selling yet. Will be losing 1/2 of the US/Canada/Israeli market, but weighted heavily in favor of Relief for the rest of the world. Good news overall as far as I'm concerned.